![]() |
市场调查报告书
商品编码
1953426
动物工作站市场 - 全球产业规模、份额、趋势、机会及预测(按动物类型、最终用户、应用、设备类型、地区和竞争格局划分,2021-2031年)Animal Workstations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Animal Type, By End-user, By Application, By Equipment Type, By Region & Competition, 2021-2031F |
||||||
全球动物工作站市场预计将从 2025 年的 32.2 亿美元成长到 2031 年的 48.2 亿美元,复合年增长率为 6.95%。
这些工作站,包括生物安全柜和笼具更换站,是至关重要的防护设备,旨在保护研究人员免受过敏原和病原体的侵害,同时为动物实验对象维持无菌环境。市场扩张的主要驱动力是职业健康标准的严格执行以及生物医学研究数量的持续增长,而这些研究需要有效的过敏原管理。例如,加拿大动物照护委员会在2025年的报告中指出,“2024年,经认证的机构出于科学目的使用了3,706,907只动物”,这凸显了大规模的实验活动需要可靠的防护基础设施来满足监管要求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 32.2亿美元 |
| 市场规模:2031年 | 48.2亿美元 |
| 复合年增长率:2026-2031年 | 6.95% |
| 成长最快的细分市场 | 兽医 |
| 最大的市场 | 北美洲 |
儘管市场前景广阔,但安装和维护这些专用系统所需的大量资本投入仍构成重大障碍。许多学术机构和小规模研究机构预算紧张,往往推迟老旧设备的更换。这种财务压力阻碍了合规工作站技术的广泛应用,并在成本意识主导采购决策、限制基础设施升级的地区减缓了市场成长。
政府加大对临床前和转化研究的投入是推动先进生物安全防护系统普及应用的主要因素。随着公共卫生策略转向应对新出现的病原体,联邦机构正投入大量资金用于改造老旧的实验室基础设施并加强研究能力。这些资金使研究机构能够购买高性能工作站,在活体实验中提供必要的屏障保护,从而确保无病原体环境,并保护工作人员免受实验室相关感染。为了强调这一趋势,美国卫生与公众服务部 (HHS) 在 2024 年 3 月发布的 2024 财年预算概述中指出,美国国立卫生研究院 (NIH) 已获得 471 亿美元的项目级资金,用于支持全国范围内的生物医学研究,从而促进购置满足严格安全通讯协定所需的关键基础设施。
同时,全球生物製药开发平臺的扩张推动了对使用动物模型进行严格安全性测试通讯协定的需求。製药公司日益专注于开发治疗慢性疾病的新治疗方法,这促使越来越多的临床前研究需要精确的环境控制。为了适应日益增长的工作量,实验室依靠符合人体工学的笼具更换台和生物安全柜来最大限度地降低交叉污染风险,并确保研究的完整性。根据美国药品研究与製造商协会 (PhRMA) 于 2024 年 9 月发布的《2024 年 PhRMA 会员研发投资报告》,会员公司在 2023 年的研发投资额高达 1,035 亿美元,这表明研发工作的强度推动了对专业动物操作设备的需求。此外,英国政府内政部在 2024 年报告称,上年度英国进行了 270 万例生物科学实验,这再次强调了对生物安全防护基础设施的持续需求。
全球动物实验工作站市场面临的主要障碍之一是购买和维护这些专用隔离设备所需的大量资金投入。研究机构,尤其是学术和非营利机构,常常面临严重的资金限制,难以购置昂贵的实验室基础设施。因此,许多机构不愿投资最新的符合监管要求的系统,而是选择延长现有设备的运作。这种必要的升级延迟直接阻碍了市场扩张,延长了设备更新週期,并提高了小规模实验室的进入门槛,因为它们无法负担高昂的前期成本。
预算限制的影响因生物医学基础设施关键外部资金来源的停滞不前而加剧。根据美国大学协会 (AAU) 2024 年的一份报告,「美国国立卫生研究院 (NIH) 的联邦拨款维持在 470.8 亿美元,预算没有变化,这限制了研究机构在运营成本不断上涨的情况下的购买力。」主要津贴成长缓慢以金额为准各机构优先采购科研资本,而非采购资本。这阻碍了新动物实验工作站的购置,迫使对成本敏感的机构推迟支出以应对有限的资源。
随着科研机构努力减少其环境足迹,对永续性和节能设计的日益重视正在改变产品开发。动物饲养设施历来是高能耗环境,因此对能够降低电力消耗和热排放、从而降低整个设施空调需求的隔离基础设施有着强烈的需求。製造商正透过设计配备电动换向马达和节能模式设定的工作站来响应这一需求,以满足主要製药客户严格的脱碳目标。根据My Green Lab于2024年11月发布的《2024年生物技术和製药行业碳影响报告》,“31%的公司已设定与1.5°C目标相一致的中期目标”,这导致市场对支持这些雄心勃勃的净零排放承诺的实验室设备的需求激增。
同时に、IoTとリアルタイムデジタル监视机能の统合により、従来の动物管理ユニットはインテリジェントなデータ収集ポイントへと进化しています。现代のワークステーションには、気流速度、フィルター饱和度、环境条件を监视する组み込みセンサーが搭载されるケースが増加しており、これらのデータはコンプライアンス检验と予知保全のために集中管理システムへ自动送信されます。この数位化の流れは、业界の自动化されたデータ完全性への移行を支え、研究者が手动记録を削减し、一贯した研究条件を保证することを可能にします。ピストイア・アライアンスが2024年9月に発表した『未来の研究所2024世界の调査』で指摘されているように、「回答者の68%が现在、业务において人工知能と机械学习(AI/ML)を活用している」とされており、高品质な运用データを统合研究分析プラットフォームへ确実に供给する、接続された机器の重要性が浮き雕りとなっています。
The Global Animal Workstations Market is projected to expand from USD 3.22 Billion in 2025 to USD 4.82 Billion by 2031, registering a CAGR of 6.95%. These workstations, including biological safety cabinets and cage changing stations, are essential containment units designed to safeguard research personnel from allergens and pathogens while maintaining sterile conditions for animal subjects. Market expansion is largely driven by the strict enforcement of occupational health standards and the continuous volume of biomedical research necessitating effective allergen control. For instance, the 'Canadian Council on Animal Care' reported in '2025' that 'certified institutions reported the use of 3,706,907 animals for scientific purposes in 2024', highlighting the massive operational scale that requires dependable containment infrastructure to satisfy regulatory requirements.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.22 Billion |
| Market Size 2031 | USD 4.82 Billion |
| CAGR 2026-2031 | 6.95% |
| Fastest Growing Segment | Veterinary |
| Largest Market | North America |
Despite these growth prospects, the market faces a substantial obstacle regarding the significant capital investment needed to install and maintain these specialized systems. Many academic institutions and smaller research facilities operate under tight budgetary constraints, which often leads to the postponement of replacing aging equipment. This financial pressure hinders the wider adoption of compliant workstation technologies, thereby slowing market growth in regions where cost sensitivity dictates procurement decisions and limits infrastructure upgrades.
Market Driver
Increasing government funding for preclinical and translational research serves as a major driver for the adoption of sophisticated containment systems. As public health strategies pivot toward preparing for emerging pathogens, federal agencies are dedicating significant funds to modernize aging laboratory infrastructure and boost research capacities. This financial support enables research institutions to purchase high-performance workstations that provide necessary barrier protection during in vivo studies, ensuring pathogen-free environments and safeguarding staff from laboratory-acquired infections. Highlighting this trend, the U.S. Department of Health and Human Services noted in its 'FY 2024 Budget in Brief' from March 2024 that the National Institutes of Health (NIH) received a program level funding of '$47.1 billion' to back nationwide biomedical research, facilitating the acquisition of essential infrastructure to meet strict safety protocols.
Concurrently, the global expansion of biopharmaceutical drug development pipelines demands rigorous safety testing protocols utilizing animal models. Pharmaceutical firms are increasingly focusing on developing novel therapies for chronic diseases, resulting in a higher volume of preclinical trials that require precise environmental controls. To handle these growing workflows, laboratories depend on ergonomic cage changing stations and biological safety cabinets to minimize cross-contamination risks and guarantee study integrity. According to the Pharmaceutical Research and Manufacturers of America (PhRMA) '2024 PhRMA Member Company R&D Investment' report from September 2024, member companies invested '$103.5 billion' in R&D in 2023, demonstrating the operational intensity driving demand for specialized animal handling units. Additionally, the UK Home Office reported in 2024 that '2.7 million' scientific procedures involving living animals were conducted in Great Britain the previous year, further emphasizing the consistent need for containment infrastructure.
Market Challenge
The principal obstacle restricting the Global Animal Workstations Market is the substantial capital expenditure necessary for purchasing and maintaining these specialized containment units. Research facilities, especially within academic and non-profit sectors, frequently face stringent fiscal limitations that complicate the procurement of expensive laboratory infrastructure. Consequently, institutions often choose to prolong the operational life of legacy equipment instead of investing in modern compliant systems. This delay in necessary upgrades directly hampers market expansion by extending replacement cycles and establishing high barriers to entry for smaller laboratories unable to bear the significant upfront costs.
The effect of these budgetary restrictions is further intensified by the stagnation of key external funding streams essential for biomedical infrastructure. As stated by the 'Association of American Universities' in '2024', 'federal funding for the National Institutes of Health was enacted at $47.08 billion, a figure representing a flat budget that limits the purchasing power of research institutions amidst rising operational costs'. This lack of growth in primary grant funding compels organizations to prioritize immediate research consumables over long-term capital investments. As a result, the adoption of new animal workstations is impeded, with cost-sensitive facilities deferring expenditures to accommodate their limited financial resources.
Market Trends
The emphasis on sustainability and energy-efficient engineering is transforming product development as research facilities aim to minimize their environmental impact. Vivariums have historically been energy-intensive environments, driving a strong demand for containment infrastructure that reduces power consumption and heat output to lower facility-wide HVAC demands. Manufacturers are addressing this by designing workstations with electrically commuted motors and eco-mode settings that meet the strict decarbonization goals of major pharmaceutical clients. According to the '2024 Carbon Impact of Biotech & Pharma Report' by My Green Lab in November 2024, '31% of companies have set medium-term targets aligned with a 1.5°C pathway', creating a critical market need for laboratory equipment that supports these ambitious net-zero commitments.
Simultaneously, the integration of IoT and real-time digital monitoring capabilities is evolving traditional animal handling units into intelligent data collection points. Modern workstations are increasingly fitted with embedded sensors that monitor airflow velocity, filter saturation, and environmental conditions, automatically sending this data to centralized facility management systems for compliance verification and predictive maintenance. This digital shift supports the industry's move toward automated data integrity, enabling researchers to reduce manual logging and guarantee consistent study conditions. As noted by the Pistoia Alliance in their 'Lab of the Future 2024 Global Survey' from September 2024, '68% of respondents are currently using Artificial Intelligence and Machine Learning (AI/ML) in their work', highlighting the importance of connected equipment that reliably feeds high-quality operational data into integrated research analytics platforms.
Report Scope
In this report, the Global Animal Workstations Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Animal Workstations Market.
Global Animal Workstations Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: